Nortech Systems Inc. 10-K Summary (Fiscal Year Ended Dec 31, 2000)
Business Context and Reporting Period
Nortech Systems Inc. is a Minnesota-based contract manufacturer specializing in wire harnesses, cables, electronic sub-assemblies, and printed circuit board assemblies. The company serves medical, industrial, automotive, and defense sectors. As of December 31, 2000, the company operates solely within its Contract Manufacturing segment following the discontinuation of its Display Products and Medical Management segments in 1999 and 2000. The reporting period covers the fiscal year ended December 31, 2000.
Key Financial Metrics
| Metric | 2000 | 1999 |
|---|---|---|
| Revenue (Sales) | $54,751,226 | $38,482,335 |
| Gross Profit | $10,355,945 | $6,510,781 |
| Gross Margin | 18.9% | 16.9% |
| Net Income (Continuing Ops) | $2,043,573 | $1,070,799 |
| EPS (Basic, Continuing Ops) | $0.86 | $0.46 |
| Operating Cash Flow | $855,040 | $2,981,330 |
| Total Assets | $28,652,949 | $23,603,716 |
| Total Long-Term Debt | $7,665,536 | $10,246,911 |
| Working Capital | $9,633,539 | $9,691,189 |
Note: Working Capital calculated as Total Current Assets minus Total Current Liabilities.
Material Changes vs. Prior Period
- Revenue Growth: Sales increased by 42.4% ($16.3 million) driven by internal growth within the medical and industrial customer bases.
- Profitability: Net income from continuing operations nearly doubled, rising from $1.07 million in 1999 to $2.04 million in 2000. Gross margin improved from 16.9% to 18.9%.
- Discontinued Operations: The 1999 net loss included a $3.06 million charge related to discontinued operations (Display Products and Medical Management). In 2000, these segments were fully divested or liquidated, resulting in no loss from discontinued operations for the year.
- Debt Reduction: Total long-term debt decreased by approximately $2.6 million due to principal payments, though current maturities increased significantly.
- Cash Flow: Operating cash flow decreased significantly to $0.86 million from $2.98 million in 1999, primarily due to increased investments in accounts receivable ($3.15 million increase) and inventory ($2.87 million increase) to support sales growth.
Guidance, Outlook, and Risks
- Outlook: Management expects revenue growth to continue at a moderate rate for 2001. The company anticipates meeting future financial requirements through operating cash flows and its existing line of credit.
- Market Risk: The company has variable rate borrowings. Management estimates a 10% change in interest rates would not have a material effect on 2001 earnings.
- Covenant Violation: As of December 31, 2000, the company was in violation of its current ratio covenant with Wells Fargo Bank. The bank has granted a 12-month waiver for this specific requirement.
- Customer Concentration: One customer, G.E. Medical, accounted for 13.1% of total sales in 2000.
- Backlog: The 90-day order backlog was approximately $10.6 million as of December 31, 2000, expected to be realized in the first quarter of 2001.
Investor Verification Checklist
- Verify the sustainability of the 42% revenue growth and whether it is driven by one-time orders or recurring contracts.
- Confirm the status of the current ratio covenant waiver with Wells Fargo Bank and the company's plan to return to compliance.
- Assess the impact of the significant increase in Accounts Receivable and Inventory on future working capital needs.
- Review the concentration risk associated with G.E. Medical (13.1% of sales) and the stability of that relationship.
- Monitor the realization of the $10.6 million backlog in Q1 2001 to validate revenue projections.